Primerica, Inc.

NYSE:PRI Stock Report

Market Cap: US$10.1b

Primerica Valuation

Is PRI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PRI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PRI ($300.18) is trading below our estimate of fair value ($544.69)

Significantly Below Fair Value: PRI is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PRI?

Other financial metrics that can be useful for relative valuation.

PRI key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.7x
Enterprise Value/EBITDA11.4x
PEG Ratio2.1x

Price to Earnings Ratio vs Peers

How does PRI's PE Ratio compare to its peers?

The above table shows the PE ratio for PRI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average13.3x
GL Globe Life
8.5x3.8%US$9.3b
UNM Unum Group
7.4x-4.3%US$13.0b
CNO CNO Financial Group
14.8x10.9%US$4.1b
LNC Lincoln National
22.8x19.2%US$6.2b
PRI Primerica
14.5x6.8%US$10.1b

Price-To-Earnings vs Peers: PRI is expensive based on its Price-To-Earnings Ratio (14.5x) compared to the peer average (13.3x).

Price to Earnings Ratio vs Industry

How does PRI's PE Ratio compare vs other companies in the US Insurance Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a10.4%
 n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a10.4%
 n/an/an/a
No more companies

Price-To-Earnings vs Industry: PRI is expensive based on its Price-To-Earnings Ratio (14.5x) compared to the US Insurance industry average (13.2x).

Price to Earnings Ratio vs Fair Ratio

What is PRI's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PRI PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio14.5x
Fair PE Ratio15x

Price-To-Earnings vs Fair Ratio: PRI is good value based on its Price-To-Earnings Ratio (14.5x) compared to the estimated Fair Price-To-Earnings Ratio (15x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PRI forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$300.18
US$304.83
+1.6%
6.5%US$340.00US$283.00n/a6
Nov ’25US$274.44
US$291.00
+6.0%
4.3%US$314.00US$277.00n/a6
Oct ’25US$265.71
US$275.20
+3.6%
6.1%US$300.00US$249.00n/a5
Sep ’25US$263.23
US$275.20
+4.5%
6.1%US$300.00US$249.00n/a5
Aug ’25US$252.32
US$260.50
+3.2%
5.6%US$275.00US$243.00n/a4
Jul ’25US$237.29
US$252.75
+6.5%
5.7%US$275.00US$236.00n/a4
Jun ’25US$225.89
US$252.50
+11.8%
5.9%US$275.00US$235.00n/a4
May ’25US$215.51
US$255.00
+18.3%
5.7%US$275.00US$235.00n/a4
Apr ’25US$252.00
US$248.00
-1.6%
8.4%US$275.00US$217.00n/a4
Mar ’25US$248.73
US$248.00
-0.3%
8.4%US$275.00US$217.00n/a4
Feb ’25US$229.48
US$230.60
+0.5%
8.7%US$260.00US$204.00n/a5
Jan ’25US$205.76
US$225.80
+9.7%
10.5%US$260.00US$200.00n/a5
Dec ’24US$210.23
US$225.80
+7.4%
10.5%US$260.00US$200.00n/a5
Nov ’24US$194.38
US$220.20
+13.3%
12.8%US$260.00US$185.00US$274.445
Oct ’24US$194.01
US$220.40
+13.6%
12.7%US$260.00US$185.00US$265.715
Sep ’24US$204.46
US$220.60
+7.9%
12.7%US$260.00US$185.00US$263.235
Aug ’24US$214.45
US$212.00
-1.1%
13.0%US$244.00US$170.00US$252.325
Jul ’24US$197.76
US$206.80
+4.6%
11.9%US$244.00US$170.00US$237.295
Jun ’24US$181.45
US$199.20
+9.8%
14.9%US$244.00US$162.00US$225.895
May ’24US$184.13
US$197.50
+7.3%
13.5%US$244.00US$160.00US$215.516
Apr ’24US$172.24
US$188.60
+9.5%
9.3%US$210.00US$162.00US$252.005
Mar ’24US$191.13
US$184.80
-3.3%
11.7%US$210.00US$156.00US$248.735
Feb ’24US$162.57
US$164.00
+0.9%
7.8%US$187.00US$150.00US$229.485
Jan ’24US$141.82
US$158.20
+11.5%
10.3%US$187.00US$137.00US$205.765
Dec ’23US$147.92
US$158.20
+6.9%
10.3%US$187.00US$137.00US$210.235
Nov ’23US$145.37
US$154.80
+6.5%
11.6%US$187.00US$135.00US$194.385

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y